VX-702

• Target:

  Autophagy|||p38 MAPK

• Related Pathways:

  Autophagy|||MAPK

• Purity:

  >99.99%

• Bioactivity:

  VX-702 is a highly specific p38? MAPK inhibitor, 14-fold higher selectivity for the p38? than p38?. VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA) .

• Smiles:

  NC (=O) N (c1ccc (C (N) =O) c (n1) -c1ccc (F) cc1F) c1c (F) cccc1F

• Molecular Formula:

  C19H12F4N4O2

• Molecular Weight:

  404.32

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  745833-23-2